QuantiFERON TB-gold conversion rate among psoriasis patients under biologics: a 9-year retrospective study.

Matteo Megna Maria Ferrillo Ruggiero Angelo Eleonora CinelliLucia GalloGabriella Fabbrocini

Published in: International journal of dermatology (2020)

Annual TB screening is important in psoriasis patients under biologic treatment in order to avoid possible latent TB infection reactivation. Indeed, our data showed that even in a low TB prevalence country like Italy, QFT may convert over time in psoriasis patients under biologics in 6.5% of the cases.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
mycobacterium tuberculosis
prognostic factors
rheumatoid arthritis
peritoneal dialysis
machine learning
artificial intelligence
electronic health record
patient reported